Gestational trophoblastic disease: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
Line 17: | Line 17: | ||
}} | }} | ||
{{SI}} | {{SI}} | ||
{{CMG}} | {{CMG}} | ||
==Overview== | ==Overview== |
Revision as of 13:11, 6 October 2015
For patient information on Hydatiform mole, click here
For patient information on Choriocarcinoma, click here
Gestational trophoblastic disease | |
DiseasesDB | 2602 |
---|---|
MedlinePlus | 001496 |
MeSH | D031901 |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Gestational trophoblastic disease, usually referred to as a mole, is a very rare abnormality of pregnancy in the reproductive female that involves abnormal trophoblast proliferation.
Classification
There are profound differences in pathological morphology and clinical behavior in various forms of GTD. Types include:
- Abnormal placenta, mostly due to abnormal fertilization
- Hydatidiform mole (HM)
- Frank malignant tumors of trophoblast
- Invasive mole, choriocarcinoma (CCA)
- Placental site trophoblastic tumor (PSTT)
- Epithelioid trophoblastic tumor (ETT)
- Not true neoplasms, representing abnormally formed placentas
- Exaggerated placenta site (EPS)
- Placental site nodule (PSN)
Pathophysiology
It is the result of a (purely chance) genetic error during the fertilization process that in turn causes the growth of abnormal tissue (which is not an embryo) within the uterus. The growth of this material is disproportionately rapid when compared to normal fetal growth.